---
title: "Cybin publishes MD&A for year ended March 31, 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291141255.md"
description: "Cybin published its MD&A for the year ended March 31, 2026. The company switched presentation currency to USD, moved its U.S. listing from NYSE American to Nasdaq under ticker HELP, and rebranded as Helus Pharma. It plans to seek shareholder approval to change its legal name to Helus Pharma Inc. and completed a 1-for-38 share consolidation, with prior-period figures restated accordingly."
datetime: "2026-06-29T12:00:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291141255.md)
  - [en](https://longbridge.com/en/news/291141255.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291141255.md)
generator: "portal-rs"
---

# Cybin publishes MD&A for year ended March 31, 2026

-   Cybin published its MD&A for the year ended March 31, 2026. \* Presentation currency switched to USD from April 1, 2025 to better match the cost base and improve peer comparability. \* U.S. listing moved from NYSE American to Nasdaq under ticker HELP; business rebranded to Helus Pharma. \* Plans to seek shareholder approval to change the legal name to Helus Pharma Inc. \* Completed a 1-for-38 share consolidation; prior-period per-share figures restated to reflect the consolidation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cybin Inc. published the original content used to generate this news brief on June 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CYBN.US](https://longbridge.com/en/quote/CYBN.US.md)
- [HELP.US](https://longbridge.com/en/quote/HELP.US.md)

## Related News & Research

- [Cybin announces annual general and special shareholder meeting](https://longbridge.com/en/news/296336431.md)
- [Cybin renames key subsidiaries under Helus reorganization plan](https://longbridge.com/en/news/295929080.md)
- [LSL Pharma Group Inc. reports Q2 results](https://longbridge.com/en/news/296953883.md)
- [Vidac Pharma board member Dr. Max Herzberg sells Vidac Pharma shares for EUR 6,450](https://longbridge.com/en/news/296702900.md)
- [What is Zacks Research's Forecast for MD Q1 Earnings?](https://longbridge.com/en/news/296480548.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**